New York, NY, United States of America

Colby Suire

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 2.3

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Colby Suire: Innovator in Stem Cell Research

Introduction

Colby Suire is a notable inventor based in New York, NY, who has made significant contributions to the field of stem cell research. With a total of three patents to his name, Suire's work focuses on advancing cell culture methods and therapeutic applications for mesenchymal stem cells.

Latest Patents

One of Suire's latest patents is a cell culture method for mesenchymal stem cells. This patent discloses a cell culture medium that promotes cell proliferation during serum-free cell culture. Another important patent is related to a potency assay, which outlines a method for determining the biological activity or therapeutic efficacy of cultured mesenchymal lineage precursor cells or stem cells based on their released TGF-9 levels in culture. This invention also includes isolated populations of mesenchymal lineage precursor cells or stem cells selected based on the level of TGF-9 released by such cells in culture. Furthermore, it relates to the treatment of subjects suffering from degenerative disc disease by administering these selected cell populations.

Career Highlights

Throughout his career, Colby Suire has worked with prominent companies in the field, including Mesoblast International Sarl and Mesoblast International Sárl. His innovative approaches have positioned him as a key figure in stem cell research and development.

Collaborations

Suire has collaborated with notable individuals in his field, including Paul Simmons and Fiona See, who have contributed to his research endeavors.

Conclusion

Colby Suire's contributions to stem cell research through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in therapeutic applications for degenerative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…